Cancer stem cells in haematological malignancies
- PMID: 25691816
- PMCID: PMC4322525
- DOI: 10.5114/wo.2014.47127
Cancer stem cells in haematological malignancies
Abstract
At least several types of human haematological malignancies can now be seen as 'stem-cell diseases'. The best-studied in this context is acute myeloid leukaemia (AML). It has been shown that these diseases are driven by a pool of 'leukaemia stem cells (LSC)', which remain in the quiescent state, have the capacity to survive and self-renew, and are responsible for the recurrence of cancer after classical chemotherapy. It has been understood that LSC must be eliminated in order to cure patients suffering from haematological cancers. Recent advances in LSC research have allowed for description of LSC phenotype and identification of potential targets for anti-LSC therapies. This concise review summarises the current view on LSC biology and targeted approaches against LSC.
Keywords: cancer recurrence; chemotherapy resistance; leukaemia stem cell; self-renewal; targeted therapies.
References
-
- Iyer KS, Saksena VN. A stochastic model for the growth of cells in cancer. Biometrics. 1970;26:401–10. - PubMed
-
- Jackson EB, Brues AM. Studies on a Transplantable Embryoma of the Mouse. Cancer Res. 1941;1:494–8.
-
- Makino S. Further evidence favoring the concept of the stem cell in ascites tumors of rats. Ann N Y Acad Sci. 1956;63:818–30. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources